[{"from": "human", "value": "Provide a brief overview of this molecule. [C][O][C][=C][Branch1][#Branch2][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][F][C][C@][Branch1][=Branch2][C@@H1][C][N][C][C][O][Ring1][=Branch1][Branch1][=Branch2][C][C][C][O][C][C][Ring1][=Branch1][O]"}, {"from": "gpt", "value": "The molecule is a drug which acts as a selective norepinephrine reuptake inhibitor and is currently under development by Eli Lilly for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant treatment. Edivoxetine failed to be approved for major depressive disorder after phase III clinical trials in 2012."}]